HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Adriano Salaroli Selected Research
Adriano Salaroli Research Topics
Disease
10
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2016 - 01/2011
4
Neoplasms (Cancer)
10/2021 - 01/2020
4
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2014 - 10/2011
3
Infections
01/2021 - 01/2011
3
Blast Crisis (Blast Phase)
01/2013 - 06/2011
3
Philadelphia Chromosome
01/2013 - 07/2011
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2022 - 10/2013
2
Critical Illness (Critically Ill)
10/2021 - 01/2021
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020 - 01/2013
2
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
02/2013 - 08/2012
2
Cytopenia
12/2012 - 08/2012
1
Primary Myelofibrosis (Myelosclerosis)
10/2021
1
Sepsis (Septicemia)
01/2021
1
Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
01/2021
1
Lymphoma (Lymphomas)
01/2020
1
T-Cell Lymphoma (Lymphoma, T Cell)
01/2020
1
Agammaglobulinemia (Hypogammaglobulinemia)
01/2017
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017
1
Anemia
02/2015
1
Acute Promyelocytic Leukemia
04/2013
1
monosomy Chromosome 7
12/2012
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2012
1
Refractory Anemia with Excess of Blasts (RAEM)
08/2012
1
Type 2 Diabetes Mellitus (MODY)
04/2012
1
Hematologic Neoplasms (Hematological Malignancy)
10/2011
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2011
1
Exanthema (Rash)
05/2011
1
Opportunistic Infections (Opportunistic Infection)
01/2011
1
Virus Diseases (Viral Diseases)
01/2011
1
Herpes Zoster
01/2011
Drug/Important Bio-Agent (IBA)
10
Imatinib Mesylate (Gleevec)
FDA Link
02/2015 - 01/2011
4
Azacitidine (5 Azacytidine)
FDA Link
10/2013 - 10/2011
3
Dasatinib (BMS 354825)
FDA Link
01/2013 - 07/2011
2
Interferons
IBA
01/2016 - 01/2011
2
Deferasirox
FDA Link
01/2014 - 09/2012
2
Glucose (Dextrose)
FDA Link
Generic
11/2012 - 04/2012
1
glycosylated ferritin
IBA
01/2021
1
Ferritins (Ferritin)
IBA
01/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
Interleukin-6 (Interleukin 6)
IBA
01/2021
1
Cytokines
IBA
01/2021
1
Interleukin-10 (Interleukin 10)
IBA
01/2021
1
Interleukin-18 (Interleukin 18)
IBA
01/2021
1
CD19 Antigens
IBA
01/2020
1
Chimeric Antigen Receptors
IBA
01/2020
1
Immunoglobulin G (IgG)
IBA
01/2017
1
Biological Products
IBA
01/2017
1
Interferon-alpha (Interferon Alfa)
IBA
01/2016
1
Tretinoin (Retinoic Acid)
FDA Link
Generic
04/2013
1
src-Family Kinases
IBA
01/2013
1
Tyrosine Kinase Inhibitors
IBA
01/2013
1
Mutagens
IBA
12/2012
1
Solvents
IBA
12/2012
1
Vincristine (Oncovin)
FDA Link
Generic
12/2012
1
Benzene (Benzole)
IBA
12/2012
1
Iron
IBA
09/2012
1
nilotinib
FDA Link
04/2012
1
Lenalidomide (CC 5013)
FDA Link
05/2011
Therapy/Procedure
6
Therapeutics
01/2020 - 01/2011
3
Drug Therapy (Chemotherapy)
03/2022 - 10/2011
2
Salvage Therapy
10/2013 - 04/2013
1
Noninvasive Ventilation
10/2021
1
Cell Transplantation
10/2021
1
Critical Care (Surgical Intensive Care)
10/2021
1
Resuscitation
10/2021
1
Cardiopulmonary Resuscitation (CPR)
10/2021
1
Artificial Respiration (Mechanical Ventilation)
10/2021
1
Immunotherapy
01/2020
1
Autologous Transplantation
10/2013
1
Radiotherapy
02/2013
1
Chelation Therapy (Therapy, Chelation)
09/2012